Performing immunostaining for Glut1 as a brain endothelial cell marker, we observed, as in the mouse model, a stage‐related change of blood vessel patterning with loss of network complexity and vessel diameter increase in high‐grade gliomas (Fig 4A). Here, SLC2A1 is linked to central nervous system cancer.